Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers

Table 3 Percentage Point LVEF Change by Arm

Arm	Number of Subjects	Mean	Median	Range	p-value
Doxorubicin/Sildenafil	10	−4.9	−5.5	20.0	0.4836
Doxorubicin-only	14	−2.9	−3.0	26.5	0.4836

ISSN: 2057-3804